
GSK2190915
CAS No. 936350-00-4
GSK2190915( AM-803 | Fiboflapon | GSK-2190915 )
Catalog No. M16702 CAS No. 936350-00-4
A potent, selective FLAP inhibitor with binding IC50 of 2.6 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
50MG | 743 | Get Quote |
![]() ![]() |
100MG | 1116 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGSK2190915
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective FLAP inhibitor with binding IC50 of 2.6 nM.
-
DescriptionA potent, selective FLAP inhibitor with binding IC50 of 2.6 nM; inhibits LTB4 synthesis following ionophore challenge in human whole blood with IC50 of 76 nM (5 h incubation); shows good selectivity over CYP3A4, 2C9, and 2D6; exhibits excellent preclinical toxicology, pharmacokinetics and oral bioactivity.Asthma Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsAM-803 | Fiboflapon | GSK-2190915
-
PathwayImmunology/Inflammation
-
TargetFLAP
-
RecptorFLAP
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number936350-00-4
-
Formula Weight637.8307
-
Molecular FormulaC38H43N3O4S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCCOC1=NC=C(C=C1)C2=CC=C(C=C2)CN3C4=C(C=C(C=C4)OCC5=NC=C(C=C5)C)C(=C3CC(C)(C)C(=O)O)SC(C)(C)C
-
Chemical Name1H-Indole-2-propanoic acid, 3-[(1,1-dimethylethyl)thio]-1-[[4-(6-ethoxy-3-pyridinyl)phenyl]methyl]-α,α-dimethyl-5-[(5-methyl-2-pyridinyl)methoxy]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stock NS, et al. J Med Chem. 2011 Dec 8;54(23):8013-29.
2. Lorrain DS, et al. Eur J Pharmacol. 2010 Aug 25;640(1-3):211-8.
3. Kent SE, et al. Clin Exp Allergy. 2013 Feb;43(2):177-86.
molnova catalog



related products
-
GSK2190915 sodium
A potent, selective FLAP inhibitor with binding IC50 of 2.6 nM.
-
MK-591
A potent, orally active leukotriene biosynthesis inhibitor that acts by inhibiting 5-lipoxygenase activating protein (FLAP) with IC50 of 1.6 nM in a FLAP binding assay.
-
MK-0591
A potent, specific and orally active 5-Lipoxygenase-activating protein (FLAP) inhibitor with IC50 of 1.6 nM in FLAP binding assay.